Prognostic factors that govern localized synovial sarcoma: A single institution retrospective study on 51 patients

Medical Oncology

Volumn 31, Issue 6, 2014, Pages

  Yaser, Sameer ^a   Salah, Samer ^a   Al Shatti, Marwa ^a   Abu Sheikha, Areej ^a   Shehadeh, Ahmad ^a   Sultan, Iyad ^a   Salem, Ahmad ^a   Sughayer, Maher ^a   Al Loh, Shaymaa ^a   Al Mousa, Abdelatif ^a  

^a KING HUSSEIN CANCER CENTER   (Jordan)

Author keywords

Margins; Prognosis; Radiotherapy; Survival; Synovial sarcoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; BONE METASTASIS; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYNOVIAL SARCOMA; YOUNG ADULT; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; CHILD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SARCOMA, SYNOVIAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA, SYNOVIAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901727251     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0958-8     Document Type: Article

References (38)

1. Brennan MF SS, Maki RG, et al. Sarcomas of the soft tissues and bone. DeVita VT, Hellmann S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 2005;35:1584.
2. Levi F, La Vecchia C, Randimbison L, Te VC. Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland. Eur J Cancer. 1999;35(12):1711-6. (Pubitemid 30050645)
3. Ross JA, Severson RK, Davis S, Brooks JJ. Trends in the incidence of soft tissue sarcomas in the United States from 1973 through 1987. Cancer. 1993;72(2):486-90. (Pubitemid 23193456)
4. Rydholm A, Berg NO, Gullberg B, Thorngren KG, Persson BM. Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the interrelationships between clinical and morphologic variables. Acta Pathol Microbiol Immunol Scand A Pathol. 1984;92(5):363-74.
5. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922-30. doi:10.1002/ijc.22239. (Pubitemid 44846246)
6. Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62(1):135-40. (Pubitemid 34073997)
7. Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998;338(3):153-60. doi:10.1056/NEJM199801153380303. (Pubitemid 28041862)
8. Lu YJ, Birdsall S, Summersgill B, Smedley D, Osin P, Fisher C, et al. Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma. J Pathol. 1999;187(4):490-6. doi:10.1002/(SICI)1096-9896(199903)187:4<490:AID- PATH274>3.0.CO;2-X. (Pubitemid 29118283)
9. Rubin BP, Fletcher CD, Inwards C, Montag AG, Peabody T, Qualman SJ, et al. Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors. Arch Pathol Lab Med. 2006;130(11):1616-29. doi:10.1043/1543-2165(2006)130[1616:PFTEOS]2.0.CO;2. (Pubitemid 44683789)
10. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol. 1997;15(1):350-62. (Pubitemid 27020593)
11. Wright PH, Sim FH, Soule EH, Taylor WF. Synovial sarcoma. J Bone Joint Surg Am. 1982;64(1):112-22. (Pubitemid 12144324)
12. Pack GT, Ariel IM. Synovial sarcoma (malignant synovioma); a report of 60 cases. Surgery. 1950;28(6):1047-84.
13. el-Naggar AK, Ayala AG, Abdul-Karim FW, McLemore D, Ballance WW, Garnsey L, et al. Synovial sarcoma. A DNA flow cytometric study. Cancer. 1990;65(10):2295-300. (Pubitemid 20164838)
14. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol. 1993;17(1):35-44. (Pubitemid 23011318)
15. Ferrari A, Gronchi A, Casanova M, Meazza C, Gandola L, Collini P, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004;101(3):627-34. doi:10.1002/cncr.20386. (Pubitemid 38970615)
16. Bergh P, Meis-Kindblom JM, Gherlinzoni F, Berlin O, Bacchini P, Bertoni F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999;85(12):2596-607. (Pubitemid 29272746)
17. Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18(10):2087-94. (Pubitemid 30324362)
18. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol. 2000;18(22):3794-803.
19. Cagle LA, Mirra JM, Storm FK, Roe DJ, Eilber FR. Histologic features relating to prognosis in synovial sarcoma. Cancer. 1987;59(10):1810-4. (Pubitemid 17075429)
20. Trassard M, Le Doussal V, Hacene K, Terrier P, Ranchere D, Guillou L, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001;19(2):525-34. (Pubitemid 32112867)
21. Hajdu SI, Shiu MH, Fortner JG. Tendosynovial sarcoma: a clinicopathological study of 136 cases. Cancer. 1977;39(3):1201-17. (Pubitemid 8081195)
22. Fisher C. Synovial sarcoma. Ann Diagn Pathol. 1998;2(6):401-21. (Pubitemid 128654510)
23. Schmidt D, Thum P, Harms D, Treuner J. Synovial sarcoma in children and adolescents. A report from the Kiel Pediatric Tumor Registry. Cancer. 1991;67(6):1667-72.
24. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993;217(1):72-7.
25. Cadman NL, Soule EH, Kelly PJ. Synovial sarcoma; an analysis of 34 tumors. Cancer. 1965;18:613-27.
26. Oda Y, Hashimoto H, Takeshita S, Tsuneyoshi M. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer. 1993;72(2):478-85. (Pubitemid 23193455)
27. Roth JA, Enzinger FM, Tannenbaum M. Synovial sarcoma of the neck: a followup study of 24 cases. Cancer. 1975;35(4):1243-53.
28. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996;14(4):1201-8. (Pubitemid 26105527)
29. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14(5):1679-89. (Pubitemid 26134227)
30. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranieri E, et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer. 1989;63(7):1437-51. (Pubitemid 19084571)
31. Pisters PW, O'Sullivan B, Maki RG. Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol. 2007;25(8):1003-8. doi:10.1200/JCO.2006.09.8525. (Pubitemid 350002867)
32. Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, et al.Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993;11(7):1269-75. (Pubitemid 23199129)
33. Bramwell V, Rouesse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1994;12(6):1137-49.
34. Antman K, Crowley J, Balcerzak SP, Rivkin SE, Weiss GR, Elias A, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol. 1993;11(7):1276-85. (Pubitemid 23199130)
35. Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19(5):1238-47. (Pubitemid 32202526)
36. Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, et al. Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. J Clin Oncol. 2012;30(8):850-6. doi:10.1200/JCO.2011.37. 7218.
37. Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC). The Cochrane database of systematic reviews. 2000(2):CD001419. doi:10.1002/14651858.CD001419.
38. Bramwell VH. Adjuvant chemotherapy for adult soft tissue sarcoma: is there a standard of care? J Clin Oncol. 2001;19(5):1235-7. (Pubitemid 32202525)